Automated Breast Ultrasound Systems (ABUS) Market is estimated to be US$ 11.4 Billion by 2034; Rising Demand for Personalized Medicine to Propel Market Growth

Automated Breast Ultrasound Systems (ABUS) are medical imaging devices that use sound waves to create images of breast tissue. These systems are designed to supplement mammography in breast cancer screening for women with dense breast tissue. Automated Breast Ultrasound Systems (ABUS) uses high-frequency sound waves to produce 3D images of the breast tissue. The images are captured automatically and are not dependent on operator skill or experience.

Automated Breast Ultrasound Systems (ABUS) have a variety of applications in breast imaging, breast cancer screening, preoperative planning, screening for high risk women, monitoring treatment response and breast cancer diagnosis has become a key factor in target market growth. Rapid growth of Automated Breast Ultrasound Systems (ABUS) has been driven by increased awareness of dense breast tissue. As awareness of the impact of dense breast tissue on breast cancer screening has grown and has further facilitated the demand for Automated Breast Ultrasound Systems (ABUS) Market growth with forecast period.

The report “Automated Breast Ultrasound Systems (ABUS) Market, By Type (Automated Breast Ultrasound Systems(ABUS) and Automated Breast Volume Scanner (ABVS)), By Application (Hospitals and Diagnostic Imaging Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

 Key Highlights:

• In April 2023, GE Healthcare has launched the Invenia Automated Breast Ultrasound System (ABUS) 2.0 in U.S. It includes characteristics that allow the breast examination to be adjusted dependent on the patient's body. The only FDA-approved ultrasound supplemental breast screening technique for cancer detection in dense breast tissue is this device. Using Invenia ABUS in addition to mammography can increase breast cancer detection rates by 55%.
• In May 2022, iSono Health Inc. launched “ATUSA system” for breast imaging. It is a first-of-its-kind tiny automated entire breast ultrasonography system with distinctive wearable accessories. It is also an easy-to-use piece of software for gathering and analyzing images automatically. In order to help doctors and classify breast lesions, the company has done prospective case collection studies to further validate multiple deep learning models coupled with ATUSA software.

Analyst View:

Automated Breast Ultrasound Systems (ABUS) Market looks promising to grow in future driven by growing demand for personalized medicine as the patients and healthcare providers are increasing seeking personalized approaches to breast cancer screening and diagnosis. As the technology continues to evolve, it is likely that ABUS will become an increasingly important tool in the fight against breast cancer. Advances in technology are expected to continue to make Automated Breast Ultrasound Systems more efficient, user-friendly, and affordable, making them more accessible to a wider range of healthcare providers and patients.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Automated Breast Ultrasound Systems (ABUS) Market, By Type (Automated Breast Ultrasound Systems (ABUS) and Automated Breast Volume Scanner (ABVS)), By Application (Hospitals and Diagnostic Imaging Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

Key Market Insights from the report:

Automated Breast Ultrasound Systems (ABUS) Market accounted for US$ 2.34 Billion in 2024 and is estimated to be US$ 11.4 Billion by 2034 and is anticipated to register a CAGR of 17.40%. Automated Breast Ultrasound Systems (ABUS) Market is segmented based on Type, Application and Region.

• Based on Type, Automated Breast Ultrasound Systems (ABUS) Market is segmented into Automated Breast Ultrasound Systems(ABUS) and Automated Breast Volume Scanner (ABVS).
• Based on Application, Automated Breast Ultrasound Systems (ABUS) Market is segmented into Hospitals and Diagnostic Imaging Centers.
• By Region, the Automated Breast Ultrasound Systems (ABUS) Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Automated Breast Ultrasound Systems (ABUS) Market:

The prominent players operating in the Automated Breast Ultrasound Systems (ABUS) Market includes, GE Healthcare, Hitachi Ltd., Koninklijke Philips N.V., Siemens AG, SonoCine Inc., QView Medical,Inc., Seno Medical Instruments Inc., Volpara Solutions, Delphinus Medical Technologies Inc., CapeRay and others.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- [email protected]

Website- www.prophecymarketinsights.com